127 103

Cited 0 times in

급성기 양극성우울증 약물치료 전략

Other Titles
 Pharmacological Treatment Strategies for Acute Bipolar Depression 
Authors
 김세주 
Citation
 Journal of the Korean Neuropsychiatric Association (신경정신의학), Vol.57(4) : 287-300, 2018 
Journal Title
 Journal of the Korean Neuropsychiatric Association (신경정신의학) 
ISSN
 1015-4817 
Issue Date
2018
Keywords
Acute bipolar depression ; Treatment guideline ; Atypical antipsychotics ; Mood stabilizers ; Antidepressants
Abstract
Of the different phases of bipolar disorder, bipolar depression is more prevailing and is more difficult to treat. However, there is a deficit in systemic research on the pharmacological treatment of acute bipolar depression. Therefore, consensuses on the pharmacological treatment strategies of acute bipolar depression has yet to be made. Currently, there are only three drugs approved by the Food and Drug Administration for acute bipolar depression : quetiapine, olanzapine-fluoxetine complex, and lurasidone. In clinical practice, other drugs such as mood stabilizers (lamotrigine, lithium, valproate) and/or the other atypical antipsychotics (aripiprazole, risperidone, ziprasidone) are frequently prescribed. There remains controversy on the use of antidepressants in bipolar depression. Here, we summarized the evidence of current pharmacological treatment options and reviewed treatment guidelines of acute bipolar depression from recently published studies.
Files in This Item:
T201804730.pdf.pdf Download
DOI
10.4306/jknpa.2018.57.4.287
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Se Joo(김세주) ORCID logo https://orcid.org/0000-0002-5438-8210
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/166804
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse